Frequency News and Research

RSS

SARS-CoV-2 zoonotic transmission prediction using ACE2 receptor variation is limited

In a recent study posted to the bioRxiv* preprint server, researchers at the University of Glasgow assessed the variation in angiotensin-converting enzyme 2 (ACE2) in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) host prediction.

19 May 2022

Physician mistreatment and discrimination can have a ripple effect on the health care system

In a recent survey of more than 6,500 physicians from across the United States representing a broad spectrum of racial and ethnic diversity, nearly 30% of respondents reported experiencing discrimination and mistreatment from patients or patients' family members or visitors.

19 May 2022

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Researchers evaluated the humoral and T lymphocyte immune responses against SARS-CoV-2 variants of concern among mild COVID-19 convalescent patients in South Australia.

19 May 2022

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Researchers assessed the impact of the BNT162b2 SARS-CoV-2 vaccine-induced memory T cells on the SARS-CoV-2 Omicron variant.

19 May 2022

Researchers combine two emerging imaging technologies to better view biomolecules

A research team from Carnegie Mellon University and Columbia have combined two emerging imaging technologies to better view a wide range of biomolecules, including proteins, lipids and DNA, at the nanoscale.

19 May 2022

Prevalence of long COVID-19 after Omicron infection

A recent article posted to the medRxiv* preprint server analyzed the long coronavirus disease (COVID) linked with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant.

18 May 2022

Study explores COVID-19's lingering impacts on survivors and local communities

A Japanese research team looking at COVID-19's lingering impacts on survivors and local communities found that having a mild case of COVID-19, smoking status, comorbidities, or your sex aren't significant predictors to tell if you are less likely to develop long-term symptoms but age is.

18 May 2022

Scientists report complex mutation pattern of Omicron BA.2

Recently, scientists have studied the mutation profile of SARS-CoV-2 Omicron BA.2 and analyzed its outcome based on the interaction with receptor and/or monoclonal antibodies.

18 May 2022

Only some coronaviruses found to have pandemic-causing potential

In a new study, scientists focused on resolving the mystery of why some coronaviruses have the potential of causing a pandemic while others do not.

18 May 2022

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

In a new study, researchers evaluated the BNT162b2 coronavirus disease 2019 mRNA vaccine (antigen)-specific immune response among myeloid dysplastic syndrome and chronic lymphocytic leukemia patients.

18 May 2022

Insight into sustained-release drug delivery systems

In this interview, News-Medical speaks to Thanh T. Nguyen, a project manager at Innocore Pharmaceuticals, about the mechanisms behind long-acting injectables.

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 18 May 2022

Researchers create artificial cell membrane that can be kept stable for over 50 days

In nature, the cell membrane has a unique function of protecting the internal from the external environment and communicating outside by sensing the external chemical or physical stimuli like the most precise biosensor for life.

18 May 2022

Twitter chatter identifies fraudulent COVID-19 products early

In a recent study posted to the medRxiv* pre-print server, researchers evaluated methods that could automatically and quickly detect counterfeit coronavirus disease 2019 (COVID-19) prevention and treatment products using Twitter chats.

18 May 2022

3rd dose of COVID mRNA vaccine expands memory and capacity of immune system to combat Omicron

Researchers from the United States have now found that the immune recall induced by a two-dose primary series of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination after an initial natural infection highly improves the longevity of the antibodies as well as induces an enhanced breadth of protection across the SARS-CoV-2 variants.

17 May 2022

Frequency News and Research

SARS-CoV-2 zoonotic transmission prediction using ACE2 receptor variation is limited

Physician mistreatment and discrimination can have a ripple effect on the health care system

SARS-CoV-2 Omicron found to be more immune evasive than other variants among mild COVID-19 convalescent patients

Study explores polyfunctionality of BNT162b2 COVID-19 vaccine-induced memory T-cells

Researchers combine two emerging imaging technologies to better view biomolecules

Prevalence of long COVID-19 after Omicron infection

Study explores COVID-19's lingering impacts on survivors and local communities

Scientists report complex mutation pattern of Omicron BA.2

Only some coronaviruses found to have pandemic-causing potential

Triple BNT162b2 vaccination found to establish long-term T lymphocyte immunity among MDS and CLL patients

Insight into sustained-release drug delivery systems

Researchers create artificial cell membrane that can be kept stable for over 50 days

Twitter chatter identifies fraudulent COVID-19 products early

3rd dose of COVID mRNA vaccine expands memory and capacity of immune system to combat Omicron

Dense breasts and benign breast disease associated with elevated risk of breast cancer

Evaluating SARS-CoV-2 infection risk in indoor environments

Characterizing SARS-CoV-2 non-structural protein 15 endoribonuclease variants

Triple vaccination found to confer immune protection against SARS-CoV-2 Omicron BA.2 sublineage

Unique antibody responses after third COVID-19 mRNA vaccination

Everything You Need to Know About Autoclave Cleaning

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News